Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TTS-Fentanyl in Chronic Non-Malignant Pain
NCT01816243Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Apr 2004
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fentanyl (transdermal patch + oral transmucosal lozenge) in chronic pain, sponsored by Janssen Pharmaceutical. Started Apr 2004; status: completed.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT01816243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01816243.